Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 669 results for "continuous renal replacement therapy"

Pharmacokinetics of meropenem in children receiving continuous...

Abstract Meropenem is frequently prescribed in critically ill children receiving continuous renal replacement therapy (CRRT). We previously used clinical trial simulations to evaluate dosing regimens of meropenem in this population and reported a ... Journal of Clinical Pharmacology, 6 days ago

Tedizolid Adsorption and Transmembrane Clearance during in vitro Continuous Renal Replacement Therapy

General Please address all your queries or problem reports to the Pay-per-View Customer Service at ppv@karger.com referring to PPV or PPV account. 1. All payments are by credit card only. The transaction is secure: standard-procedure SSL or ...
 Blood Purification1 month ago
Renal & Urology News

Higher colistin dose during continuous renal replacement therapy: look before leaping!

We read with great interest the comments of Rocco and colleagues on colistin dosing in a recent letter in Critical Care [ 1 ]. The application of continuous renal replacement therapy (CRRT) indeed offers an opportunity to prescribe ...
 Critical Care1 month ago Adverse Events Common During Continuous Renal Replacement Therapy  Renal & Urology News1 month ago

Improved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell Therapy

Abstract Autosomal recessive polycystic kidney disease is a truly catastrophic monogenetic disease, causing death and end stage renal disease in neonates and children. Using PCK female rats, an orthologous model of autosomal recessive polycystic ...
 Plosone.org1 month ago
India Today

Cardiac Breakthroughs

Heart disease continues to be the leading cause of illness and death in India and indeed across the world. But researchers are labouring on many fronts to find new ways to understand and treat this serious disease. What has changed: from lab bench ...
 Yahoo! India1 day ago

Barcelona continues to grow at speed

Barcelona is a smart city that both embraces and pioneers change. Provided to China Daily City combines innovation, investment and sustainability to stay ahead of the crowd Things just keep getting better in the vibrant city of Barcelona, the ...
 CHINAdaily.com.cn1 week ago
TheStreet.com

European Commission Approves Merck's Anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab), for Both First-line and Previously-treated Patients with Advanced Melanoma

KEYTRUDA Demonstrated Superior Survival versus Ipilimumab in a Phase 3 Clinical Trial KENILWORTH, N.J.--(EON: Enhanced Online News Today's European approval supports our goal of accelerating immuno-oncology research for the benefit of patients ...
 EON: Enhanced Online News1 week ago CheckMate -025, a Pivotal Phase III Opdivo (nivolumab) Renal Cell Cancer Trial, Stopped Early  Business Wire2 weeks ago MERCK : European Commission Approves Merck's Anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab), for Both First-line and Previously-treated Patients with Advanced Melanoma  4 Traders1 week ago BRISTOL MYERS SQUIBB : CheckMate -025, a Pivotal Phase III Opdivo (nivolumab) Renal Cell Cancer Trial, Stopped Early  4 Traders2 weeks ago
[x]  

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

In systemic amyloidosis, the extracellular deposition of normally soluble plasma proteins as insoluble amyloid fibrils damages the structure and function of tissues and organs. 1 Current treatment consists of support or replacement of failing organs ...
 New England Journal of Medicine2 weeks ago

Rockwell Medical Schedules Second Quarter Earnings Call

(GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ( RMTI ), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, ...
 Yahoo! Finance1 week ago Rockwell Medical Announces Triferic(TM) Phase 3 CRUISE Studies Published in Nephrology Dialysis Transplantation  Individual.com2 weeks ago ROCKWELL MEDICAL : Schedules Second Quarter Earnings Call  4 Traders1 week ago ROCKWELL MEDICAL : Announces Triferic(TM) Phase 3 CRUISE Studies Published in Nephrology Dialysis Transplantation  4 Traders2 weeks ago
[x]  

Genzyme Strengthens Endocrinology Portfolio with Acquisition of Rare Disease Therapy Caprelsa ® (vandetanib) from AstraZeneca

Company Website: http://www.genzyme.com CAMBRIDGE, Mass. -- (Business Wire) Genzyme, a Sanofi company, today announced that it has entered into a definitive agreement with AstraZeneca to acquire Caprelsa® (vandetanib), a rare disease therapy, ...
 Stockwatch1 week ago Sanofi: Genzyme Strengthens Endocrinology Portfolio with Acquisition of Rare Disease Therapy Caprelsa® (vandetanib) from AstraZeneca  Biotechgate1 week ago REG-Sanofi: Genzyme Strengthens Endocrinology Portfolio with Acquisition of Rare Disease Therapy Caprelsa(R) (vandetanib) from AstraZeneca  Reuters1 week ago SANOFI : Genzyme Strengthens Endocrinology Portfolio with Acquisition of Rare Disease Therapy Caprelsa® (vandetanib) from AstraZeneca  4 Traders1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less